C13H14F2N4OS
Neat
312.34
-20°C
Room Temperature
368421-58-3; DTXSID301127991; (alphaR, betaR)-beta-(2, 5-Difluorophenyl)-beta-hydroxy-alpha-methyl-1H-1, 2, 4-triazole-1-butanethioamide; RefChem:405726; DTXCID401559494; (2R, 3R)-3-(2, 5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1, 2, 4-triazol-1-yl)butanethioamide; (2R, 3R)-3-(2, 5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1, 2, 4-triazol-1-yl)thiobutyramide; MFCD28404611; (2R, 3R)-3-(2, 5-difluorophenyl)-3-hydroxy-2-methyl-4-(1, 2 and 4-triazol-1-yl)butanethioamide; C13H14F2N4OS; 1286729-96-1; UWVOPVUWKIHGRF-ISVAXAHUSA-N; Isavuconazole Impurity G; DJ2EAK2W8C; SCHEMBL1660790; SCHEMBL30524180; Isavuconazole Related Compound 12; CS-M3468; AKOS027327319; AC-31069
(2R, 3R)-3-(2, 5-difluorophenyl)-3-hydroxy-2-methyl-4-(1, 2 and 4-triazol-1-yl)butanethioamide
InChI=1S/C13H14F2N4OS/c1-8(12(16)21)13(20,5-19-7-17-6-18-19)10-4-9(14)2-3-11(10)15/h2-4,6-8,20H,5H2,1H3,(H2,16,21)/t8-,13+/m0/s1